TeselaGen Stock
TeselaGen is accelerating the design and fabrication of DNA with synthetic biology software.
Sign up today and learn more about TeselaGen Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About TeselaGen Stock
TeselaGen is building a rapid prototyping system for fast bio-based construction of sustainably sourced chemicals, therapeutic medicines, and novel vaccines. Their customers are biopharmaceutical and bioindustrial companies like Amgen and Genomatica. Their bioCAD/CAM system is based on technology exclusively licensed from Lawrence Berkeley National Lab and is being beta tested by hundreds of users.
Management
Founder and Chief Scientific Officer
Nathan Hillson
Founder & CEO
Michael Fero
Founder & CTO
Eduardo Abeliuk
Team Member
Nick Elsbree
Press
patents - Apr, 15 2024
Method for efficiently optimizing a phenotype with a combination of a …patents - Apr, 15 2024
Method, apparatus, and computer-readable medium for optimal pooling of nucleic …patents - Apr, 15 2024
Method, apparatus, and computer-readable medium for efficiently optimizing a …patents - Apr, 15 2024
Method, apparatus, and computer-readable medium for efficiently optimizing a …agribusinessglobal - Feb, 17 2024
TeselaGen Announces Spin-Off, Built Biotechnologies, Aims to Advance DNA ManufacturingEquityZen Recognized As:
